I PATENTSCOPE
`
`Search International and National Patent Collections
`Browse ® Translate
`'t=l News
`
`r Q. Search
`
`What is this?
`
`Try the new look J O f) l
`
`+ + + [ Machine translation '
`1. (WO2005049061 ) PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION
`DEVICES
`
`~"
`
`rr PCT Biblio. Data 1 Description
`
`Claims
`
`National Phase
`
`Notices
`
`Documents
`
`Latest bibliographic data on file with the International Bureau
`
`Permalink <s®
`
`Pub. No.:
`Publication Date:
`IPC:
`
`Applicants:
`
`International Application No.: PCT/DK2004l000792
`WO/2005/049061
`International Filing Date:
`18.11.2004
`02.06.2005
`A61K 38126 (2006.01) ,A61K 38128 (2006.01) ,A61K 47/10 (2006.01) ,A61K 47/18 (2006.01) ,A61K 47120 (2006.01) ,A61K
`47/26 (2006.01)
`NOVO NORDISK A/S [DK/DK]; Novo Alie DK-2880 Bagsvrerd, DK (AIIExceptUS)
`PEDERSEN, Tina Bjeldskov [DK/DK]; DK (UsOnly)
`BONDE, Claude (FR/DK]; DK (UsOnly)
`ENGELUND, Dorthe Kot [DK/DK]; DK (UsOnly)
`
`Inventors:
`
`Priority Data:
`
`Title
`
`Abstract:
`
`Des ignated States:
`
`Publication Language:
`Filing Language:
`Also published as:
`
`l
`
`PEDERSEN, Tina Bjeldskov; DK
`BONDE, Claude; DK
`ENGELUND, Dorthe Kot; DK
`
`PA 2003 01719 20.11.2003 DK
`(EN) PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE
`IN INJECTION DEVICES
`(FR) FORMULATIONS PEPTIDIQUES A BASE DE PROPYLENE GLYCOL OPTIMALES POUR LA PRODUCTION ET
`L'UTILISATION DANS DES DISPOSITIFS D'INJECTION
`(EN) The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of
`preparing such formulations, and to uses of such formu-lations in the treatment of diseases and conditions for which use of the
`peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of
`injection devices by a peptide formulation and for reducing deposits on pro-duction equipment during production of a peptide
`formulation.
`(FR) L'invention concerne des formulations pharmaceutiques comprenant un peptide et un propylene glycol. Elle conceme
`egalement des precedes permettant de preparer et d'utiliser ces formulations dans le traitement de maladies et d'etats qui requierent
`!'utilisation du peptide contenu dans ces formulations. L'invention conceme egalement des precedes permettant de reduire le
`colmatage des dispositifs d'injection par une formulation peptidique ainsi que les depots sur l'equipement de production lors de la
`production d'une formulation peptidique.
`AE, AG, AL, AM, AT, AU, AZ., BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, OM, DZ, EC, EE, EG, ES, Fl, GB,
`GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ,
`NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU,
`ZA,ZM, ZW
`African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, Ml, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
`Eurasian Patent Organization (AM, Al, BY, KG, Kl, MD, RU, T J, TM)
`European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, FR, GB, GR, HU, IE, IS, IT, LU, MC, NL, PL, PT, RO, SE, SI,
`SK, TR)
`African Intellectual Property Organization (BF, BJ, CF, CG, Cl, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
`English (EN)
`English (EN)
`MXPA/a/2006/005581 KR1020060100428 EP1687019 JP2007513084 EP2394656 US20120225810
`JP2012188424
`RU0002421238
`CN1882356 CN102784386 CA2545034 AU2004290862
`IN2771/DELNP12006 DK1687019
`ES2660320 EP3300721
`PT1687019
`
`FRESENIUS EXHIBIT 1076
`Page 1 of 1
`
`